Author:
Ravindranathan Deepak,Alhalabi Omar,Rafei Hind,Shah Amishi Yogesh,Bilen Mehmet Asim
Publisher
Springer International Publishing
Reference275 articles.
1. Siegel, R. L., Miller, K. D., & Jemal, A. (2015). Cancer statistics, 2015. CA: A Cancer Journal for Clinicians, 65(1), 5–29.
2. Fisher, R., Gore, M., Larkin, J. (Eds.). (2013). Current and future systemic treatments for renal cell carcinoma. Seminars in Cancer Biology, 23(1), 38–45. Elsevier.
3. Howlader, N., Noone, A., Krapcho, M., Miller, D., Bishop, K., Kosary, C., et al. (2017). SEER cancer statistics review, 1975–2014. National Cancer Institute;2018.
4. Heng, D. Y., Xie, W., Regan, M. M., Warren, M. A., Golshayan, A. R., Sahi, C., et al. (2009). Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: Results from a large, multicenter study. Journal of Clinical Oncology, 27(34), 5794–5799.
5. Motzer, R. J., Mazumdar, M., Bacik, J., Berg, W., Amsterdam, A., & Ferrara, J. (1999). Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. Journal of Clinical Oncology, 17(8), 2530–2540.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献